Form4insider filings, from the source

SEC Form 4 · accession 0001144204-17-048556

CASI Pharmaceuticals, Inc. · CASI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Wei-Wu He
Director
Period of report
Sep 14, 2017
Accepted (ET)
Sep 18, 2017 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 14, 2017P187,625$1.22A212,323D
Common StockF1Sep 15, 2017P127,702$1.49A340,025D
Common StockF2holding———1,871,605ISee Footnote
Common StockF3holding———441,072ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses